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Background and purpose: Multiple sclerosis (MS) has been associated with
deﬁcits in social cognition. However, little is known about which domains of
social cognition are predominantly aﬀected and what other factors are associ-
ated with it. The aim was (i) to characterize social cognition deﬁcit in a group
of MS outpatients and (ii) to relate impairment in social cognition to overall
cognitive status, depression and fatigue.
Methods: Thirty-ﬁve MS patients (mean disease duration 12.9 years, median
Expanded Disability Status Scale (EDSS) 3 and 34 healthy controls (HCs)
were examined using the German version of the Geneva Social Cognition
Scale to measure diﬀerent domains of social cognition. Standard neuropsycho-
logical testing was applied to all patients and to 20 HCs. Patient-reported out-
comes included questionnaires for fatigue, depression, anxiety and executive-
behavioural disturbances.
Results: The mean social cognition raw score was lower in the MS patients
compared to the HCs (86.5  8.7 vs. 91.2  5.9, P = 0.005; d = 0.6) and did
not correlate with EDSS or disease duration. The diﬀerence was driven by
facial aﬀect recognition and the understanding of complex social situations
(14% and 23% of patients respectively under the cut-oﬀ). The impairment in
these two tasks did not correlate with general cognitive performance or depres-
sion but with fatigue.
Conclusions: The impairment in our group was restricted to high order and
aﬀective social cognition tasks and independent of general cognitive perfor-
mance, EDSS, disease duration and depression. Fatigue correlated with social
cognition performance, which might be due to common underlying neuronal
networks.
Introduction
Social cognition (SC) concerns the processing of infor-
mation that inﬂuences our behaviour towards other
people. It relies on the knowledge of unwritten social
rules and the ability to infer from given information,
guess what others might be feeling and correctly judge
a situation [1]. It is sub-served by a large brain
network including the temporo-parietal, medial pre-
frontal and anterior cingulate cortex [1]. Theory of
mind (ToM) is one factor of SC, referring to the abil-
ity to make inferences about the mental status of
other people and to understand their emotions and
beliefs [1].
Social cognition abilities can be divided into various
subdomains, such as facial aﬀect recognition, under-
standing of someone else’s state of mind/ToM (false
belief tasks) or comprehension of complex social situ-
ations (faux pas tasks). These subdomains can be
grouped into categories, such as ‘verbal/non-verbal’
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depending on their verbal demands and ‘emotional/
cognitive’ depending on the complexity of their emo-
tional components [2]. The level of complexity varies
across tasks. ‘Social cognition stories’, ‘faux pas’ and
facial aﬀect recognition are considered high order
ToM tasks [3], whereas ‘false belief’ tasks are con-
sidered less complex, appearing earlier in normal
development.
Functional cognitive and aﬀective alterations associ-
ated with impaired frontal-subcortical connectivity
play an important role in the everyday disabilities of
multiple sclerosis (MS) patients [4]. Given the large
network implicated in SC, and as other conditions
with disruption of subcortical-frontal connectivity
have been associated with SC deﬁcits [5], MS is
expected to have an impact on this process [6]. Most
studies (19/23, Appendix S3, Table S1) showed that
SC is impaired in MS [7–14]. However, it remains
unclear which subdomains are predominantly aﬀected,
since many of these studies [10,14] included only one
aspect (13/23) or did not directly compare the diﬀer-
ent domains of SC (3/23) [11].
Little is known about factors inﬂuencing SC perfor-
mance in MS patients. Depression is more frequent in
MS patients than in the general population and fati-
gue is one of the most common symptoms of MS.
Both have been thought to interfere with cognitive
testing [15]. Whilst literature on the eﬀect of fatigue
on SC is rare, an eﬀect of major depression on SC
abilities has been described [16]. As SC diﬀers mean-
ingfully from other aspects of cognitive functionality
[17], people with MS might have diﬃculties in inter-
personal contexts even in the absence of marked exec-
utive dysfunctions and physical disability.
The aim of the present study was to characterize SC
deﬁcits in MS patients and to assess whether or not
impairment in certain subdomains is associated with
disease duration, physical or overall cognitive deﬁcits,
depression and fatigue.
Participants and methods
The study was approved by the Ethics Committee of
North West Switzerland (Reference 49/12). Written
informed consent by subjects/next-of-kin was provided
by all patients and controls.
Patients
Thirty-nine MS patients were recruited from the MS
outpatient clinic of the University Hospital, Basel, and
neurological practices in the northwest of Switzerland.
Inclusion criteria were a diagnosis of MS or clinically
isolated syndrome according to the revised McDonald
criteria 2005 [18]; Expanded Disability Status Scale
(EDSS) [19] score ≤7.0; free of corticosteroid treatment
and relapses for at least 2 months; ﬂuency in German.
Exclusion criteria were severe cognitive impairment
including the inability to participate in cognitive testing;
major depression; medication or comorbidities that
may aﬀect cognition (e.g. schizophrenia or bipolar
disorder leading to hospitalization).
Figure 1 Social cognition score in
patients and controls. The dotted line
indicates the cut-oﬀ. The “o” and “*”
indicate outliers.
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Four patients withdrew their consent due to
scheduling problems or because of the long duration
(2 h) of the testing sessions. In total, 35 patients were
tested between November 2012 and January 2013
either in the Institute for Psychology, Basel, or at the
University Hospital Basel and are included in this
analysis. Subject characteristics are given in Table 1.
Thirty-four age-, gender- and education-matched
healthy individuals from Basel and Berne served as
controls (HCs). HCs had no known neurological dis-
eases and did not take any drugs that aﬀect cognitive
function. Each rater was instructed by a senior expert
neurologist or neuropsychologist (JMA, IKP) in a
training session.
Geneva Social Cognition Scale (GeSoCS)
An original German version of the GeSoCS [20], used
for clinical assessment of SC in neurological disorders,
was used. Information on the translation process and
the German version of the GeSoCS is given in the
Supporting material (Appendices S1, S2 and S4)
(http://www.unifr.ch/neurology/fr/clinic/pubclnic).
The test consisted of the following subtests: (i) ‘so-
cial cognition stories’, verbal stories, including a faux
pas task; (ii) a short version of Baron Cohen’s ‘read-
ing the mind in the eyes’ (MIE) test, a facial aﬀect
recognition task; (iii) ‘cartoon stories’, non-verbal
false belief tasks; (iv) ‘inference test’ short stories
where conclusions have to be drawn from given infor-
mation; (v) ‘absurd stories’, short situations without
social aspect; (vi) ‘temporal rules’, an executive func-
tions task.
A maximum of 100 points could be achieved. The
test duration was 30 min. Details are given elsewhere
[20].
Standard neuropsychological test battery
A 90 min neuropsychological test was applied to MS
patients and to 20 HCs. It included the Verbal Learn-
ing and Memory Test [21], the Brief Visuospatial
Memory Test revised [22], semantic and phonemic
verbal ﬂuency [23], Digit Span and Corsi-Block from
the Wechsler Memory Scale [24] and the Symbol Digit
Modalities Test [25].
Questionnaires
Fatigue and depression/anxiety were assessed by the
Fatigue Scale for Motor and Cognitive Functions
(FSMC) [26] and the Hospital Anxiety and Depres-
sion Scale [27]. To measure behavioural changes close
relatives were asked to complete the Dysexecutive
Questionnaire [28].
Statistical analysis
Data were presented as mean  standard deviation
(SD) or median (range) depending on the distribution.
The chi-squared test was used to compare categorical
variables. The MannWhitney U test or the t test for
independent samples was used to compare outcome
measures between groups and the Spearman q or Pear-
son correlation tests to assess associations between
variables depending on the normality of the data (Sha-
piroWilk test). Results were further analysed using a
linear regression model with demographic data (age,
gender, education) as independent covariates. Because
of the non-normal distribution of data, signiﬁcant
results were conﬁrmed by bootstrap analysis (case re-
sampling, n = 1000). Cut-oﬀ values were deﬁned as the
mean value minus two standard deviations in the
Table 1 Demographic data of MS patients and controls
Healthy
controls MS patients Signiﬁcance (P)
N 34 35
Age in years, mean (SD) 43.9 (12.5) 43.8 (12.13) 0.91
Female 22/34 (64.7%) 22/35 (60%) 0.69
Level of education
Obligatory school education only (11 years) 0 1 0.49
Apprenticeship 20 19
Thirteen years school education and
university admission qualiﬁcation
2 5
Completed university study 12 10
EDSS median (range) NA 3.0 (0–6.5)
Disease duration in years, mean (SD) NA 12.9 (9.6)
Clinical course of MS (n) NA Relapsingremitting 25; primary progressive 8;
secondary progressive 2
MS, multiple sclerosis; EDSS, Expanded Disability Status Scale.
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control group. Given the exploratory nature of this
study and the potential problems associated with for-
mally correcting for multiple comparisons [29], ﬂagged
results using the conventional signiﬁcance threshold
(P < 0.05) are presented. SPSS version 21 for statisti-
cal analysis (Chicago, IL, USA) was used.
Results
Social cognition scores in patients versus controls
Patients showed lower total SC scores than HCs
(86.5  8.7 vs. 91.2  5.9, P = 0.005, post hoc calcu-
lated statistical power 0.81, d = 0.63; ﬁg. 1). The diﬀer-
ence remained signiﬁcant after adjusting for age, gender
and education using a linear regression model (adjusted
P = 0.008). Three patients (8.6%) had lower scores
than the cut-oﬀ value (<79.3). No diﬀerence was found
between relapsing and progressive MS (P = 0.55).
The diﬀerences between patients and HCs were dri-
ven by the subtests ‘social cognition stories’
(P = 0.006, d = 0.64) (Table 2) and MIE (P = 0.035,
d = 0.57), again remaining signiﬁcant after adjusting
for age, gender and education using a linear regression
model (P = 0.012 and 0.004, respectively). The num-
ber of patients who scored below the cut-oﬀ in ‘social
cognition stories’ and MIE was eight (23%) and ﬁve
(14%). Sixteen (46%) patients scored below the cut-
oﬀ in at least one subtest.
Association between neurological disability, cognitive
functions and social cognition scores
There was no correlation between the total SC score
and EDSS or disease duration. The neuropsychologi-
cal test scores in the patient group were marginally
lower than in HCs without reaching statistical signiﬁ-
cance (Table 3). The diﬀerence between MS patients
and controls remained signiﬁcant excluding patients
who scored below the cut-oﬀ in two or more of the
neuropsychological tests (n = 30 remaining, total score
P = 0.012).
In the patients’ group, ‘social cognition stories’ and
MIE did not correlate with any other neuropsycholog-
ical test scores. The global SC score correlated with
verbal memory (q = 0.384, P = 0.025), visuospatial
memory (q = 0.472, P = 0.01) and verbal ﬂuency
(q = 0.381, P = 0.024).
Associations between social cognition, fatigue and
depression
Fatigue and depression scores were higher in patients
than controls (Table 4).
There was no correlation between SC and depression
scores in MS patients. The diﬀerence in SC between
MS patients and HCs remained signiﬁcant even when
depression was considered (corrected P = 0.027).
Twenty-two patients suﬀered from fatigue according
to the validated cut-oﬀ values [26]; 14 were classiﬁed
as severe.
Total and cognitive fatigue were correlated with SC
(q = 0.424, P = 0.016), conﬁrmed by linear regres-
sion analysis (P = 0.001) and bootstrap. When cor-
rected for fatigue, the diﬀerences between MS patients
and controls in the SC score were no longer signiﬁ-
cant (total score P = 0.36, ‘social cognition stories’
P = 0.2, MIE P = 0.19)
Discussion
Consistent with most published studies (Appendix S3,
Table S1) SC impairment was found in MS patients
compared with HCs on a group level.
The prevalence of this impairment in our cohort,
including patients with a mild-to-moderate disability
Table 2 Median and range for results in the total score and subtests
of the GeSoCS (all non-normally distributed)
HCs
(n = 34)
MS
(n = 35)
Signiﬁcance
(P)
Social cognition
total score
92 (76–100) 88 (52–98) 0.005*
Social cognition
stories
20 (16–20) 20 (14–20) 0.006*
Reading the mind
in the eyes
16 (10–20) 14 (4–18) 0.035*
Cartoon stories 20 (17–20) 19.5 (12–20) 0.148
Inference test 19 (14–20) 18 (10–20) 0.604
Absurd stories 10 (6–10) 10 (6–10) 0.275
Temporal rules 10 (6–10) 10 (6–10) 0.101
*Signiﬁcant results (P > 0.05). GeSoCS, Geneva Social Cognition
Scale; HC, healthy control; MS, multiple sclerosis.
Table 3 Mean values (SD) for results in neuropsychological tests
Neuropsychological test
MS
(n = 35)
Controls
(n = 20) Signiﬁcance (P)
Symbol Digit
Modalities Test
50.2 (16.5) 57.4 (13.1) 0.85
Verbal Learning and
Memory Test (n = 34)
58.7 (11.3) 60.1 (6.06) 0.57
Brief Visuospatial
Memory Test
25.3 (6.7) 25.1 (6.9) 0.91
Phonological
ﬂuency: words
21.2 (7.8) 23.7 (6.7) 0.23
Semantic
ﬂuency: animals
32.3 (9.4) 35.7 (9.2) 0.19
Digit Span 14.0 (3.5) 15.8 (3.6) 0.08
Block Span 16.3 (3.2) 17.4 (2.9) 0.19
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(median EDSS 3), was 9%, reaching 24% for facial aﬀect
recognition. A prevalence of up to 66% [9] has been
described for impairment in facial aﬀect recognition. This
variability may be due to inﬂuences by diﬀerent neuro-
logical deﬁcits or patterns of lesion load and suggests
that SC abilities should be tested in each patient.
The strength of the present study is that diﬀerent
dimensions of SC were investigated. Until now,
mostly one-dimensional tests have been used. A study
by Jehna and colleagues [30], for example, tested only
one aspect of SC and found no diﬀerence between
MS patients and controls. This underlines the impor-
tance of using a tool like the GeSoCS, which provides
a broader view of performance in diﬀerent categories.
Two subtests most sensitive to diﬀerentiate patients
from HCs were found: ‘social cognition stories’ and
MIE. These ﬁndings are supported by a recent review
[31] on ToM in MS, which also found deﬁcits in over-
all ToM performance as well as facial aﬀect recogni-
tion and the interpretation of social situations. The
performance of MS patients in faux pas tasks, how-
ever, was conserved but with great heterogeneity in
the data on this point.
Both facial aﬀect recognition and faux pas tasks are
considered complex ToM tasks [2]. Our results suggest
that physicians should carefully choose the tests for
MS patients. In our population the tests most sensible
to detect changes in SC performance are high order
tests.
Our data support evidence on impairment in MS
patients in both verbal and non-verbal ToM [7,10].
The most aﬀected tasks in our study were the verbal
‘social cognition stories’ and the non-verbal MIE.
Both tasks focus on the aﬀective component of ToM,
whereas for example false belief tasks rely more on
cognitive aspects of ToM [2]. A deﬁcit in emotional
recognition and alexithymia in MS patients has been
discussed [10,14] and can be the underlying cause for
a disruption of aﬀective ToM functions.
Social cognition deﬁcit can occur independently or
secondary to deﬁcits in other cognitive domains [31].
The driving subtests were found to be independent,
suggesting that SC, although not entirely independent
of other cognitive functions, represents a separate
entity of socio-cognitive functioning. The reported
correlations [8,10] between SC and other cognitive
domains may correspond to a mediating role between
executive dysfunction and ToM deﬁcits.
Statistically, the diﬀerence in SC between patients
and controls was not independent of fatigue. How-
ever, this does not necessarily mean that fatigue is
confounding our results; fatigue and SC may share
similar pathophysiological mechanisms. Both fatigue
and SC impairment can be caused by a widespread
brain network dysfunction and are associated with
reduced function of the right prefrontal and anterior
cingulate cortex and structural loss of ﬁbre integrity
in the frontal white matter [1,32]. In previous studies,
SC in MS patients was independent from fatigue
[9,13]. However, a direct comparison with our results
is diﬃcult, as these studies used diﬀerent fatigue scales
(Modiﬁed Fatigue Impact Scale versus FSMC) and
neither of them stated the prevalence of fatigue in
their MS group. Future studies should further include
validated and detailed scales of fatigue to better
understand its impact on SC.
Limitations
The number of subjects chosen for our study was suf-
ﬁcient to depict the diﬀerence in SC between the
patient and control groups. It was too small, however,
for any further secondary analysis. The relatively low
number of patients and controls also increased the
risk for type 2 errors. The mild level of overall cogni-
tive disability in this group may have inﬂuenced the
results, especially the lack of association between
general cognitive impairment and SC performance.
Larger studies including patients with more severe
cognitive impairment are warranted.
The GeSoCS has not been validated in German.
However, the ability to diﬀerentiate patients from
controls in most of its subtests is well established [20].
The scale is too long for quick screening in MS
patients and should be used as part of a clinical neu-
ropsychological testing or be adapted to the diseases,
choosing for example the most sensitive of its
subtests.
Conclusions
Impairment in our group was restricted to high order
and aﬀective SC tasks, such as aﬀect recognition and
faux pas. This ﬁnding might be useful when consider-
ing new simple evaluation tools for daily practice.
Table 4 Median (range) and signiﬁcance of between-group diﬀer-
ences for results in questionnaires
MS Controls
Signiﬁcance
(P)
Fatigue total score 52 (21–94) 32 (20–62) <0.001*
Motor fatigue 32.5 (11–47) 17 (10–29) 0.005*
Cognitive fatigue 23.5 (10–48) 12.5 (10–33) 0.000*
Anxiety 5 (0–14) 4 (0–9) 0.058
Depression 3 (0–12) 1 (0–5) 0.000*
Executive-behavioural
disturbances
9.5 (0–55) 10.5 (0–27) 0.846
*Signiﬁcant results (P > 0.05)
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Although not entirely independent of other cognitive
functions, SC deﬁcit appears to be a separate entity of
socio-cognitive impairment. The impairment occurs
independently of neurological disability and disease
duration; therefore physicians and nurses need to be
aware of it at any stage of the disease. Fatigue corre-
lated with SC performance, which might reﬂect intri-
cate underlying neuronal networks.
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